Fingerprint
Dive into the research topics of 'An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia
David A. Rizzieri, Sarah A Cooley, Olatoyosi Odenike, Lisette Moonan, Kay Hoong Chow, Kimberley Jackson, Xuejing Wang, Leslie Brail, Gautam Borthakur
Research output: Contribution to journal › Article › peer-review
51
Scopus
citations